237 related articles for article (PubMed ID: 28799413)
1. An Initial Open Trial of a Brief Behavioral Activation Treatment for Depression and Medication Adherence in HIV-Infected Patients.
Tull MT; Berghoff CR; Bardeen JR; Schoenleber M; Konkle-Parker DJ
Behav Modif; 2018 Mar; 42(2):196-209. PubMed ID: 28799413
[TBL] [Abstract][Full Text] [Related]
2. Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse.
Willie TC; Overstreet NM; Sullivan TP; Sikkema KJ; Hansen NB
Behav Med; 2016; 42(2):120-7. PubMed ID: 26010763
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.
Webb MS; Vanable PA; Carey MP; Blair DC
AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957
[TBL] [Abstract][Full Text] [Related]
4. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
Safren SA; O'Cleirigh CM; Bullis JR; Otto MW; Stein MD; Pollack MH
J Consult Clin Psychol; 2012 Jun; 80(3):404-15. PubMed ID: 22545737
[TBL] [Abstract][Full Text] [Related]
6. [Adherence to HAART, quality of life and psychopathological symptoms among HIV/AIDS infected patients].
Margalho R; Pereira M; Ouakinin S; Canavarro MC
Acta Med Port; 2011 Dec; 24 Suppl 2():539-48. PubMed ID: 22849945
[TBL] [Abstract][Full Text] [Related]
7. HIV Anxiety Reduction/Management Program (HAMRT): pilot randomized controlled trial.
Brandt CP; Paulus DJ; Lopez-Gamundi P; Green C; Lemaire C; Zvolensky MJ
AIDS Care; 2019 Dec; 31(12):1527-1532. PubMed ID: 30957525
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria.
Adejumo O; Oladeji B; Akpa O; Malee K; Baiyewu O; Ogunniyi A; Evans S; Berzins B; Taiwo B
Int J STD AIDS; 2016 Oct; 27(11):938-49. PubMed ID: 26384949
[TBL] [Abstract][Full Text] [Related]
9. Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy.
Krumme AA; Kaigamba F; Binagwaho A; Murray MB; Rich ML; Franke MF
J Epidemiol Community Health; 2015 Mar; 69(3):284-9. PubMed ID: 25385745
[TBL] [Abstract][Full Text] [Related]
10. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol.
Claborn K; Becker S; Operario D; Safren S; Rich JD; Ramsey S
Addict Sci Clin Pract; 2018 Apr; 13(1):12. PubMed ID: 29606129
[TBL] [Abstract][Full Text] [Related]
11. Relationship between depressive symptoms, alcohol use, and antiretroviral therapy adherence among HIV-infected, clinic-attending patients in South Africa.
Magidson JF; Saal W; Nel A; Remmert JE; Kagee A
J Health Psychol; 2017 Sep; 22(11):1426-1433. PubMed ID: 26884445
[TBL] [Abstract][Full Text] [Related]
12. Anxiety, depression and treatment adherence among HIV-infected migrants.
Been SK; Schadé A; Bassant N; Kastelijns M; Pogány K; Verbon A
AIDS Care; 2019 Aug; 31(8):979-987. PubMed ID: 30957530
[TBL] [Abstract][Full Text] [Related]
13. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.
Memiah P; Shumba C; Etienne-Mesubi M; Agbor S; Hossain MB; Komba P; Niyang M; Biadgilign S
J Int Assoc Provid AIDS Care; 2014; 13(4):346-52. PubMed ID: 24114726
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.
Paydary K; Ekhtiari H; Noori M; Rad MV; Hajiabdolbaghi M; SeyedAlinaghi S
Infect Disord Drug Targets; 2015; 15(3):177-83. PubMed ID: 26411558
[TBL] [Abstract][Full Text] [Related]
15. Mindfulness instruction for HIV-infected youth: a randomized controlled trial.
Webb L; Perry-Parrish C; Ellen J; Sibinga E
AIDS Care; 2018 Jun; 30(6):688-695. PubMed ID: 29067834
[TBL] [Abstract][Full Text] [Related]
16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
17. Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil.
Betancur MN; Lins L; Oliveira IR; Brites C
Braz J Infect Dis; 2017; 21(5):507-514. PubMed ID: 28535397
[TBL] [Abstract][Full Text] [Related]
18. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
[TBL] [Abstract][Full Text] [Related]
20. Acceptance-based behavior therapy to promote HIV medication adherence.
Moitra E; Herbert JD; Forman EM
AIDS Care; 2011 Dec; 23(12):1660-7. PubMed ID: 21732897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
